Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to determine the efficacy and safety of lamotrigine in patients with trigeminal neuralgia (TGN).

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Malaya
• Treatments: Anticonvulsants; Carbamazepine; Lamotrigine

Criteria

Inclusion Criteria:

• Clinical diagnosis of Trigeminal Neuralgia

• Male; or non-pregnant/non-lactating female

• Must be willing to cooperate with and understands study instructions

• Signed informed consent prior to entering study

Exclusion Criteria:

• psychiatric illness

• severe liver or cardiovascular disease

• renal impairment, low white cell count

• malignancy

• pregnancy or lactation

• alcohol or recreational drug abuse

• and positive tests for human immunodeficiency virus or hepatitis B or C.